Market revenue in 2022 | USD 861.9 million |
Market revenue in 2030 | USD 1,632.2 million |
Growth rate | 8.3% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 97.39% in 2022. Horizon Databook has segmented the India menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study published by the Journal of Mid-Life Health in March 2019, menopausal age in Indian women is around 4-5 years lower than women in western countries, leading to early onset of hot flashes.
There has been an increase in awareness about women’s health in the country, along with a growing trend of adopting Ayurvedic supplements such as Shatavari for easing symptoms such as hot flashes, as well as Ashwagandha-based supplements. The early onset of menopause and increasing adoption of dietary supplements are likely to boost the demand for dietary supplements in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account